XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent consideration
6 Months Ended
Dec. 31, 2022
Statement [line items]  
Contingent consideration
Note 14. Contingent consideration
 
    
Consolidated
 
    
December
    
June 2022
 
    
2022
    
Restated *
 
    
$
    
$
 
Contingent consideration - Paxalisib
     652,174        —    
Contingent consideration – EVT801
     786,287        758,840  
    
 
 
    
 
 
 
     
       1,438,461        758,840  
    
 
 
    
 
 
 
See also Note 16 setting out non-current contingent consideration.